All Stories

  1. The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and luticasone propionate via Accuhaler® (ENERGITO® study)

    Article • International Journal of Chronic Obstructive Pulmonary Disease, February 2016, Dove Medical Press

    Dr Dongmei Zhai, Alan Hamilton